Blog
RSS FeedPosted by Michael Wonder on 15 Aug 2023
New treatments for people with chronic migraine and soft tissue sarcoma added to the PBS
14 August 2023 - From August 2023, Australians with chronic migraine and soft tissue sarcoma will have access to new ...
Posted by Michael Wonder on 10 Aug 2023
Medicine costs to halve after Labor wins 60 day dispensing vote
10 August 2023 - More than six million Australians will have the cost of their medicines halved within weeks as ...
Posted by Michael Wonder on 09 Aug 2023
Senate showdown on 60 day dispensing
9 August 2023 - Health Minister Mark Butler has accused the Coalition and Pharmacy Guild of Australia of wanting to ...
Posted by Michael Wonder on 01 Aug 2023
Global sarcoma therapy now listed on Pharmaceutical Benefits Scheme
31 July 2023 - Yondelis (trabectedin) demonstrates 45% reduction in risk of disease progression or death versus dacarbazine. ...
Posted by Michael Wonder on 31 Jul 2023
Schedule of Pharmaceutical Benefits - 1 August 2023
1 August 2023 - The August 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 31 Jul 2023
International harmonisation of ingredient names - changes to the PBS Schedule effective 1 August 2023
PBAC - The PBS Schedule has been updated in the 1 August 2023 Schedule to show sole ingredient names for ...
Posted by Michael Wonder on 26 Jul 2023
DoH publishes agenda for November 2023 PBAC meeting
26 July 2023 - The agenda for the November 2023 PBAC meeting is now available. ...
Posted by Michael Wonder on 20 Jul 2023
DUSC utilisation analysis public release documents (February 2023)
20 July 2023 - The utilisation analysis public release documents from the February 2023 DUSC meeting are now available. ...
Posted by Michael Wonder on 18 Jul 2023
DoH publishes revised agenda (version 4) for July 2023 PBAC meeting
18 July 2023 - The DoH has chosen to publish another version after the event. ...
Posted by Michael Wonder on 18 Jul 2023
Outcome statement - June 2023 DUSC meeting
18 July 2023 - The outcome statement from the June 2023 DUSC meeting is now available. ...
Posted by Michael Wonder on 16 Jul 2023
Public summary documents (first time decisions not to recommend and deferrals) – March 2023 PBAC meeting
14 July 2023 - The public summary documents (first time decisions not to recommend and deferrals) from the March 2023 PBAC ...
Posted by Michael Wonder on 10 Jul 2023
Recommendations made out of session by the PBAC March 2023 and July 2023 meetings – changes to MS-2 Step PBS listing
11 July 2023 - In an out of session consideration, the PBAC has recommended changes to the restriction criteria and eligible ...
Posted by Michael Wonder on 07 Jul 2023
PBS subsidy arrangements for insulin degludec and insulin aspart
7 July 2023 - The Department of Health and Aged Care has made amendments to the National Health (Pharmaceutical Benefits) (Pharmacist ...
Posted by Michael Wonder on 03 Jul 2023
Pharmacies get major financial boost from 1 July
3 July 2023 - On the 75th anniversary of the Chifley Labor Government’s introduction of the PBS, Australia’s strong and sustainable ...
Posted by Michael Wonder on 02 Jul 2023
Widened eligibility for oral antiviral Paxlovid, plus new medicines on PBS
2 July 2023 - From 1 July 2023, Australians with severe thrombocytopenia and diabetic kidney disease will have access to ...